Genetic evolution of a fetoprotein producing gastric cancer

被引:32
作者
Fujii, H
Ichikawa, K
Takagaki, T
Nakanishi, Y
Ikegami, M
Hirose, S
Shimoda, T
机构
[1] Juntendo Univ, Sch Med, Dept Pathol 2, Bunkyo Ku, Tokyo 1138421, Japan
[2] Dokkyo Univ, Sch Med, Dept Pathol, Mibu, Tochigi, Japan
[3] Natl Canc Ctr Res Inst & Hosp, Div Pathol, Tokyo, Japan
[4] Jikei Univ, Sch Med, Tokyo, Japan
关键词
D O I
10.1136/jcp.56.12.942
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: a Fetoprotein (AFP) producing gastric cancer is an unusual form of aggressive adenocarcinoma with a complex histological picture, including enteroblastic and hepatoid differentiation. Aims: To investigate the genetic events underlying the phenotypic diversity in AFP producing gastric cancer and the ability of these tumours to produce AFP ectopically. Methods: Multiple foci from 19 AFP producing gastric adenocarcinomas were microdissected and loss of heterozygosity (LOH) analysis was performed with a panel of microsatellite markers on nine chromosomal arms. Results: For informative cases, LOH was most frequently detected on 17p (100%), followed by 13q (88%), 3p (87%), 5q and 9p (80%), 11q (70%), 18q (58%), 16q (53%), and 8p (50%). The average fractional allelic loss was 0.72. LOH was detected either homogeneously throughout the microdissected foci, or only in some parts of the neoplastic foci for each case. Heterogeneous patterns of LOH indicated genetic progression and/or divergence in clonal evolution. Furthermore, in six cases with heterogeneous LOH of 13q, 13q LOH was restricted to immunohistochemically AFP positive neoplastic foci. Conclusion: AFP-GC arises as an aggressive clone with extensive LOH and high fractional allelic loss. The presence of heterogeneous patterns of LOH suggested that the AFP producing carcinoma foci might evolve through genetic progression and/or genetic divergence. Silencing of the crucial gene on 13q may be involved in the acquisition of the AFP producing phenotype.
引用
收藏
页码:942 / 949
页数:8
相关论文
共 45 条
[1]  
Alpert E, 1976, Prog Liver Dis, V5, P337
[2]  
BOURREILLE J, 1970, PRESSE MED, V78, P1277
[3]  
CHANG YC, 1990, AM J GASTROENTEROL, V85, P1480
[4]  
Cho JH, 1996, LAB INVEST, V74, P835
[5]   Fractional allelic loss in gastric carcinoma correlates with growth patterns [J].
Choi, SW ;
Park, SW ;
Lee, KY ;
Kim, KM ;
Chung, YJ ;
Rhyu, MG .
ONCOGENE, 1998, 17 (20) :2655-2659
[6]  
DELORIMIER A, 1993, CANCER, V71, P293, DOI 10.1002/1097-0142(19930115)71:2<293::AID-CNCR2820710204>3.0.CO
[7]  
2-O
[8]  
Fujii H, 2000, CANCER RES, V60, P114
[9]   Genetic classification of combined hepatocellular-cholangiocarcinoma [J].
Fujii, H ;
Zhu, XG ;
Matsumoto, T ;
Inagaki, M ;
Tokusashi, Y ;
Miyokawa, N ;
Fukusato, T ;
Uekusa, T ;
Takagaki, T ;
Kadowaki, N ;
Shirai, T .
HUMAN PATHOLOGY, 2000, 31 (09) :1011-1017
[10]  
GITLIN D, 1972, CANCER RES, V32, P979